These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 30059968)

  • 1. Understanding variation in prevalence estimates of polycystic ovary syndrome: a systematic review and meta-analysis.
    Skiba MA; Islam RM; Bell RJ; Davis SR
    Hum Reprod Update; 2018 Nov; 24(6):694-709. PubMed ID: 30059968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis.
    Bozdag G; Mumusoglu S; Zengin D; Karabulut E; Yildiz BO
    Hum Reprod; 2016 Dec; 31(12):2841-2855. PubMed ID: 27664216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of community-based reference ranges to estimate the prevalence of polycystic ovary syndrome by the recognised diagnostic criteria, a cross-sectional study.
    Skiba MA; Bell RJ; Herbert D; Garcia AM; Islam RM; Davis SR
    Hum Reprod; 2021 May; 36(6):1611-1620. PubMed ID: 33846715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of PCOS and related hyperandrogenic traits in premenopausal women with type 1 diabetes: a systematic review and meta-analysis.
    Bayona A; Martínez-Vaello V; Zamora J; Nattero-Chávez L; Luque-Ramírez M; Escobar-Morreale HF
    Hum Reprod Update; 2022 Jun; 28(4):501-517. PubMed ID: 35237802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
    Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
    Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria.
    Yildiz BO; Bozdag G; Yapici Z; Esinler I; Yarali H
    Hum Reprod; 2012 Oct; 27(10):3067-73. PubMed ID: 22777527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H; Tanir HM; Yildiz Z
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome: an androgen excess and PCOS society resource.
    Azziz R; Kintziger K; Li R; Laven J; Morin-Papunen L; Merkin SS; Teede H; Yildiz BO
    Hum Reprod; 2019 Nov; 34(11):2254-2265. PubMed ID: 31751476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors.
    Broekmans FJ; Knauff EA; Valkenburg O; Laven JS; Eijkemans MJ; Fauser BC
    BJOG; 2006 Oct; 113(10):1210-7. PubMed ID: 16972863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Polycystic ovary syndrome: is there a rise in the prevalence?].
    Carmona-Ruiz IO; Saucedo-de la Llata E; Moraga-Sánchez MR; Romeu-Sarró A
    Ginecol Obstet Mex; 2015 Dec; 83(12):750-9. PubMed ID: 27290799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study.
    Farhadi-Azar M; Behboudi-Gandevani S; Rahmati M; Mahboobifard F; Khalili Pouya E; Ramezani Tehrani F; Azizi F
    Front Endocrinol (Lausanne); 2022; 13():825528. PubMed ID: 35299965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis.
    Cooney LG; Lee I; Sammel MD; Dokras A
    Hum Reprod; 2017 May; 32(5):1075-1091. PubMed ID: 28333286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study.
    Tehrani FR; Simbar M; Tohidi M; Hosseinpanah F; Azizi F
    Reprod Biol Endocrinol; 2011 Mar; 9():39. PubMed ID: 21435276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. To what extent does the use of the Rotterdam criteria affect the prevalence of polycystic ovary syndrome? A community-based study from the Southwest of Iran.
    Rashidi H; Ramezani Tehrani F; Bahri Khomami M; Tohidi M; Azizi F
    Eur J Obstet Gynecol Reprod Biol; 2014 Mar; 174():100-5. PubMed ID: 24411130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycystic ovary syndrome v.2023: Simplified diagnostic criteria for an East Asian phenotype.
    Yong EL; Teoh WS; Huang ZW
    Ann Acad Med Singap; 2023 Dec; 52(12):669-678. PubMed ID: 38920160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and meta-analysis.
    Lizneva D; Kirubakaran R; Mykhalchenko K; Suturina L; Chernukha G; Diamond MP; Azziz R
    Fertil Steril; 2016 Nov; 106(6):1510-1520.e2. PubMed ID: 27530062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria.
    Franks S
    J Clin Endocrinol Metab; 2006 Mar; 91(3):786-9. PubMed ID: 16418209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of idiopathic hirsutism: A systematic review and meta-analysis.
    Amiri M; Fallahzadeh A; Sheidaei A; Mahboobifard F; Ramezani Tehrani F
    J Cosmet Dermatol; 2022 Apr; 21(4):1419-1427. PubMed ID: 34185950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome.
    Schmidt TH; Khanijow K; Cedars MI; Huddleston H; Pasch L; Wang ET; Lee J; Zane LT; Shinkai K
    JAMA Dermatol; 2016 Apr; 152(4):391-8. PubMed ID: 26720591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasonographic criteria in the diagnosis of polycystic ovary syndrome: a systematic review and diagnostic meta-analysis.
    Pea J; Bryan J; Wan C; Oldfield AL; Ganga K; Carter FE; Johnson LM; Lujan ME
    Hum Reprod Update; 2024 Jan; 30(1):109-130. PubMed ID: 37804097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.